Our top pick for
MSCI Inc is a financial data & stock exchanges business based in the US. MSCI shares (MSCI) are listed on the NYSE and all prices are listed in US Dollars. MSCI employs 3,633 staff and has a trailing 12-month revenue of around USD$1.7 billion.
|52-week range||USD$216.8943 - USD$455.0007|
|50-day moving average||USD$423.7533|
|200-day moving average||USD$390.56|
|Wall St. target price||USD$472.56|
|Dividend yield||USD$2.92 (0.7%)|
|Earnings per share (TTM)||USD$7.12|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing MSCI stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of MSCI's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
MSCI's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 57x. In other words, MSCI shares trade at around 57x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
MSCI's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.6796. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into MSCI's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
MSCI's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$947.2 million.
The EBITDA is a measure of a MSCI's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$1.7 billion|
|Operating margin TTM||52.1%|
|Gross profit TTM||USD$1.4 billion|
|Return on assets TTM||13.14%|
|Return on equity TTM||0%|
|Market capitalisation||USD$33.6 billion|
TTM: trailing 12 months
There are currently 647,329 MSCI shares held short by investors – that's known as MSCI's "short interest". This figure is 13.5% up from 570,205 last month.
There are a few different ways that this level of interest in shorting MSCI shares can be evaluated.
MSCI's "short interest ratio" (SIR) is the quantity of MSCI shares currently shorted divided by the average quantity of MSCI shares traded daily (recently around 530597.54098361). MSCI's SIR currently stands at 1.22. In other words for every 100,000 MSCI shares traded daily on the market, roughly 1220 shares are currently held short.
However MSCI's short interest can also be evaluated against the total number of MSCI shares, or, against the total number of tradable MSCI shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case MSCI's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 MSCI shares in existence, roughly 10 shares are currently held short) or 0.0091% of the tradable shares (for every 100,000 tradable MSCI shares, roughly 9 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against MSCI.
Find out more about how you can short MSCI stock.
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like MSCI.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 23.67
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and MSCI's overall score of 23.67 (as at 01/01/2019) is pretty good – landing it in it in the 35th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like MSCI is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 3.61/100
MSCI's environmental score of 3.61 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that MSCI is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 18.93/100
MSCI's social score of 18.93 puts it squarely in the 4th percentile of companies rated in the same sector. This could suggest that MSCI is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 9.13/100
MSCI's governance score puts it squarely in the 4th percentile of companies rated in the same sector. That could suggest that MSCI is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. MSCI scored a 1 out of 5 for controversy – the highest score possible, reflecting that MSCI has managed to keep its nose clean.
|Total ESG score||23.67|
|Total ESG percentile||35.06|
|Environmental score percentile||4|
|Social score percentile||4|
|Governance score percentile||4|
|Level of controversy||1|
Dividend payout ratio: 38.57% of net profits
Recently MSCI has paid out, on average, around 38.57% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.75% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), MSCI shareholders could enjoy a 0.75% return on their shares, in the form of dividend payments. In MSCI's case, that would currently equate to about $2.92 per share.
While MSCI's payout ratio might seem fairly standard, it's worth remembering that MSCI may be investing much of the rest of its net profits in future growth.
MSCI's most recent dividend payout was on 26 February 2021. The latest dividend was paid out to all shareholders who bought their shares by 18 February 2021 (the "ex-dividend date").
Over the last 12 months, MSCI's shares have ranged in value from as little as $216.8943 up to $455.0007. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while MSCI's is 0.9216. This would suggest that MSCI's shares are less volatile than average (for this exchange).
MSCI Inc., together with its subsidiaries, provides investment decision support tools for the clients to manage their investment processes worldwide. The company operates through Index, Analytics, and All Other segments. The Index segment primarily provides indexes for use in various areas of the investment process, including indexed product creation, such as ETFs, mutual funds, annuities, futures, options, structured products, over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct. The Analytics segment offers risk management, performance attribution and portfolio management content, applications, and services that provide clients with an integrated view of risk and return, and an analysis of market, credit, liquidity, and counterparty risk across various asset classes; various managed services, including consolidation of client portfolio data from various sources, review and reconciliation of input data and results, and customized reporting; and HedgePlatform to measure, evaluate, and monitor the risk of hedge fund investments. The All Other ? ESG segment provides products and services that help institutional investors understand how environmental, social, and governance (ESG) factors impact the long-term risk and opportunities in financial markets; and data and rating products for use in the construction of equity and fixed income indexes and issue index-based investment products, as well as manage, measure, and report on ESG mandates. The All Other ? Real Estate segment includes research, reporting, market data, and benchmarking offerings that provide real estate performance analytics for funds, investors, and managers; and business intelligence to real estate owners, managers, developers, and brokers. It serves asset owners and managers, financial intermediaries, and wealth managers. MSCI Inc. was founded in 1998 and is headquartered in New York, New York.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.